A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease
Public ClinicalTrials.gov record NCT00160706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Multi-national, Multi-centre, Open Label, Safety Study to Assess the Safety of Re-exposure After a Variable Interval and Subsequent Chronic Therapy With the Humanised Anti-TNF PEG Conjugate CDP870 400 mg sc, (Dosed at Weeks 0, 2 and 4 Then Every 4 Weeks), in the Treatment of Patients With Active Crohn's Disease Who Have Previously Been Withdrawn From Studies CDP870-031 or CDP870-032 Due to an Exacerbation of Crohn's Disease.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A follow-on safety study in subjects with Crohn's Disease who have previously been withdrawn from the double-blind study CDP870-031 \[NCT00152490\] or CDP870-032 \[NCT00152425\] due to an exacerbation of Crohn's Disease.
Study identification
- NCT ID
- NCT00160706
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 310 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2004 (Type not available)
- Primary completion
- May 2012 (Actual)
- Completion
- May 2012 (Actual)
- Last update posted
- Aug 7, 2018
2004 – 2012
United States locations
- U.S. sites
- 41
- U.S. states
- 22
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 45102 | Birmingham | Alabama | — | — |
| 45028 | Huntsville | Alabama | — | — |
| 45044 | Little Rock | Arkansas | — | — |
| 45095 | Orange | California | — | — |
| 45101 | San Francisco | California | — | — |
| 45130 | Colorado Springs | Colorado | — | — |
| 45094 | Gainesville | Florida | — | — |
| 45005 | Hialeah | Florida | — | — |
| 45087 | Miami | Florida | — | — |
| 45004 | North Miami Beach | Florida | — | — |
| 45016 | Chicago | Illinois | — | — |
| 45037 | Indianapolis | Indiana | — | — |
| 45019 | Lexington | Kentucky | — | — |
| 45033 | Chevy Chase | Maryland | — | — |
| 45013 | Laurel | Maryland | — | — |
| 45083 | Rochester | Minnesota | — | — |
| 45108 | Jefferson City | Missouri | — | — |
| 45035 | Berlin | New Jersey | — | — |
| 45009 | Great Neck | New York | — | — |
| 45070 | New York | New York | — | — |
| 45145 | Greenville | North Carolina | — | — |
| 45067 | High Point | North Carolina | — | — |
| 45003 | Raleigh | North Carolina | — | — |
| 45040 | Winston-Salem | North Carolina | — | — |
| 45081 | Cincinnati | Ohio | — | — |
| 45091 | Cincinnati | Ohio | — | — |
| 45054 | Dayton | Ohio | — | — |
| 45025 | Mayfield Heights | Ohio | — | — |
| 45039 | Oklahoma City | Oklahoma | — | — |
| 45041 | Tulsa | Oklahoma | — | — |
| 45093 | Hershey | Pennsylvania | — | — |
| 45113 | Germantown | Tennessee | — | — |
| 45119 | Nashville | Tennessee | — | — |
| 45022 | Houston | Texas | — | — |
| 45073 | San Antonio | Texas | — | — |
| 45139 | Salt Lake City | Utah | — | — |
| 45052 | South Ogden | Utah | — | — |
| 45134 | Charlottesville | Virginia | — | — |
| 45078 | Christiansburg | Virginia | — | — |
| 45109 | Norfolk | Virginia | — | — |
| 45141 | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 100 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00160706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 7, 2018 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00160706 live on ClinicalTrials.gov.